Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

Atypical chronic myelogenous leukemia (aCML), BCR/ABL1 negative is a rare myelodysplastic/myeloproliferative neoplasm, usually manifested with hyperleukocytosis without monocytosis or basophilia, organomegaly, and marked dysgranulopoiesis. In this review, we will discuss the classification and diagn...

Full description

Bibliographic Details
Main Authors:	Panagiotis T. Diamantopoulos, Nora-Athina Viniou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Oncology
Subjects:	atypical chronic myelogenous leukemia myelodysplastic syndrome/myeloproliferative neoplasm diagnostic criteria treatment molecular characterization
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.722507/full

Similar Items

Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
by: Poonam P Jain, et al.
Published: (2012-01-01)

Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis
by: Juan C. Gomez-Gelvez, MD, et al.
Published: (2016-03-01)

Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene
by: Marcelo Bellesso, et al.
Published: (2013-06-01)

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia
by: Leo Reap, DO, et al.
Published: (2020-01-01)

Association of Chronic Myelogenous (Basophilic) Leukemia and the BCR/ABL Mutation in a Yucatan Barrow (Sus scrofa domestica)
by: Catherine Takawira, et al.
Published: (2020-11-01)

Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
by: Rita Ahmad, et al.
Published: (2021-04-01)

Acute Myelogenous Leukemia Mimicking Fulminant Periorbital Cellulitis
by: Abbas Bagheri, et al.
Published: (2013-01-01)

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes
by: Aleksandra Skalska-Bugala, et al.
Published: (2022-03-01)

Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
by: Mousa Vatanmakanian, et al.
Published: (2019-04-01)

Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01)

Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma
by: Haitham Hilal Al-Mahrouqi, et al.
Published: (2021-01-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

<i>Trifolium Repens</i> Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
by: Federica Sarno, et al.
Published: (2020-02-01)

Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia
by: Dragoslava Đikić, et al.
Published: (2022-02-01)

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Michelle Maccarini Barcelos, et al.
Published: (2011-01-01)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011-01-01)

Chronic Myelomonocytic Leukemia Gold Jubilee
by: Eric Solary, et al.
Published: (2021-07-01)

Chronic myelogenous leukemia presenting with Morel Lavallée lesion: A case report of a rare presentation
by: Sara S. I. Mohamed, et al.
Published: (2022-12-01)

Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
by: Alessia Castellino, et al.
Published: (2021-10-01)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
by: Daniel Cacic, et al.
Published: (2021-04-01)

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia
by: S V Gritsaev, et al.
Published: (2016-07-01)

Bilateral Serous Macular Detachment in Acute Myelogenous Leukemia
by: Müge Karataş, et al.
Published: (2014-03-01)

An interesting case of bisphosphonate resistant hypercalcemia in acute myelogenous leukemia (AML)
by: Sara M. Cohen, et al.
Published: (2022-12-01)

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
by: Giovanni Martinelli, et al.
Published: (2009-02-01)

Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia
by: Ali ESER, et al.
Published: (2018-07-01)

Kidney Failure and Abdominal Discomfort as Initial Signs of Extramedullary Acute Myelogenous Leukemia
by: Peter Ferkis Steinfeld, et al.
Published: (2021-07-01)

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
by: Emole J, et al.
Published: (2016-02-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

"HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group "
by: Abdolfattah Sarafnejad, et al.
Published: (2006-09-01)

Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report
by: Jin-ping Liang, et al.
Published: (2023-09-01)

CHARACTERISTIC OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AT THE POLYCLINIC OF ONCOLOGY, DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA IN 2017
by: M. Rifqi Wiyono, et al.
Published: (2020-06-01)

Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells
by: Maiko Matsushita
Published: (2021-10-01)

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia
by: Kota Yoshifuji, et al.
Published: (2022-10-01)

Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia
by: Jiafeng Zheng, et al.
Published: (2020-12-01)

Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia
by: Xin P, et al.
Published: (2019-08-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-11-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-12-01)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011-03-01)